Apellis Pharmaceuticals, INC. (APLS) — 10-K/A Filings
All 10-K/A filings from Apellis Pharmaceuticals, INC.. Browse 1 Amended Annual Report reports with AI-powered summaries and risk analysis.
10-K/A Filings (1)
-
Apellis Pharmaceuticals Files 10-K/A Amendment
— Feb 29, 2024 Risk: medium
Apellis Pharmaceuticals, Inc. (APLS) filed a Amended Annual Report (10-K/A) with the SEC on February 29, 2024. Apellis Pharmaceuticals, Inc. filed a 10-K/A (Ann
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX